About N-[[5-(2-methylpropyl)-1,2,4-oxadiazol-3-yl]methyl]-1H-pyrazole-4-sulfonamide
N-[[5-(2-methylpropyl)-1,2,4-oxadiazol-3-yl]methyl]-1H-pyrazole-4-sulfonamide (PubChem CID 131935162) has the molecular formula C10H15N5O3S
and a molecular weight of 285.33 g/mol. Its IUPAC name is N-[[5-(2-methylpropyl)-1,2,4-oxadiazol-3-yl]methyl]-1H-pyrazole-4-sulfonamide.
Analyze N-[[5-(2-methylpropyl)-1,2,4-oxadiazol-3-yl]methyl]-1H-pyrazole-4-sulfonamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[[5-(2-methylpropyl)-1,2,4-oxadiazol-3-yl]methyl]-1H-pyrazole-4-sulfonamide?
The IUPAC name of N-[[5-(2-methylpropyl)-1,2,4-oxadiazol-3-yl]methyl]-1H-pyrazole-4-sulfonamide (CID 131935162) is N-[[5-(2-methylpropyl)-1,2,4-oxadiazol-3-yl]methyl]-1H-pyrazole-4-sulfonamide.
What is the SMILES notation for N-[[5-(2-methylpropyl)-1,2,4-oxadiazol-3-yl]methyl]-1H-pyrazole-4-sulfonamide?
The canonical SMILES for N-[[5-(2-methylpropyl)-1,2,4-oxadiazol-3-yl]methyl]-1H-pyrazole-4-sulfonamide is CC(C)Cc1nc(CNS(=O)(=O)c2cn[nH]c2)no1.
What is the InChIKey of N-[[5-(2-methylpropyl)-1,2,4-oxadiazol-3-yl]methyl]-1H-pyrazole-4-sulfonamide?
The InChIKey is HBEFIVMGDUIYIO-UHFFFAOYSA-N. The full InChI is InChI=1S/C10H15N5O3S/c1-7(2)3-10-14-9(15-18-10)6-13-19(16,17)8-4-11-12-5-8/h4-5,7,13H,3,6H2,1-2H3,(H,11,12).
What are the key properties of N-[[5-(2-methylpropyl)-1,2,4-oxadiazol-3-yl]methyl]-1H-pyrazole-4-sulfonamide?
N-[[5-(2-methylpropyl)-1,2,4-oxadiazol-3-yl]methyl]-1H-pyrazole-4-sulfonamide has a molecular weight of 285.33 g/mol, XLogP of 0.47, 6 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[5-(2-methylpropyl)-1,2,4-oxadiazol-3-yl]methyl]-1H-pyrazole-4-sulfonamide is sourced from PubChem (CID 131935162), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).